Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: May 2026 (Report No. 5)
Date of Filing: May 13, 2026
This filing serves to distribute a press release regarding the Company's compliance status with Nasdaq listing requirements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notice regarding listing compliance and does not contain financial statements or performance data.
Material Changes
The primary material event disclosed is the receipt of a formal extension from Nasdaq. The Company was granted an 180-day extension to regain compliance with the Minimum Bid Requirement.
Outlook, Risks, and Management Commentary
- Listing Status: The Company is currently non-compliant with the Nasdaq Minimum Bid Requirement but has been granted a grace period to rectify the issue.
- Compliance Timeline: The Company has 180 days from the date of the press release (May 13, 2026) to demonstrate compliance.
- Risk: Failure to regain compliance within the 180-day period could result in delisting from the Nasdaq stock market.
Investor Verification Checklist
- Verify the current trading price of Icecure Medical Ltd. to assess the severity of the Minimum Bid Requirement breach.
- Review the full text of the press release (Exhibit 99.1) for specific details on the Company's plan to regain compliance (e.g., reverse stock split).
- Monitor future filings for updates on compliance status before the 180-day deadline expires.
- Check for any concurrent announcements regarding capital raises or operational changes that might impact the stock price.